Higher, Lower HDL Cholesterol Linked to Increased Risk for Dementia

WEDNESDAY, Oct. 4, 2023 (HealthDay News) -- Higher and lower levels of high-density lipoprotein cholesterol (HDL-C) are associated with an increased risk for Alzheimer disease and related dementia (ADRD), according to a study published online Oct. 4 in Neurology.
Erin L. Ferguson, M.P.H., from the University of California in San Francisco, and colleagues examined the observational associations of HDL-C and low-density lipoprotein cholesterol (LDL-C) with incident dementia in a cohort with linked survey and electronic health record data. Participants completed a health behavior survey between 2002 and 2007, had laboratory measurements of cholesterol within two years after survey completion, and were followed through December 2020 for incident dementia, including ADRD. Data were included for 184,367 participants.
The researchers found that the risk for ADRD was elevated in association with higher and lower HDL-C values compared with the middle quantile, with hazard ratios of 1.07 and 1.15 for HDL-C in the lowest and highest quintile, respectively. There was no association seen for LDL-C with dementia risk overall, but the association was qualitatively modified by statin use. Higher LDL-C was associated with an increased risk for ADRD for statin users (53 percent of the sample) and a lower risk for nonusers (hazard ratio per 10-mg/dL increase, 1.01 and 0.98, respectively). Evidence for effect modification was seen by age with linear HDL-C, but not LDL-C.
"The elevation in dementia risk with both high and low levels of HDL cholesterol was unexpected, but these increases are small, and their clinical significance is uncertain," coauthor M. Maria Glymour, Sc.D., also from the University of California, San Francisco, said in a statement.
Abstract/Full Text (subscription or payment may be required)
Related Posts
La FDA aprueba unos refuerzos específicos para la ómicron de Pfizer y Moderna
MIÉRCOLES, 31 de agosto de 2022 (HealthDay News) -- La Administración de...
Could a Single Dose of the HPV Vaccine Be Enough?
FRIDAY, Nov. 26, 2021 (HealthDay News) -- Women getting vaccinated against the...
Six Additional Weeks of Rivaroxaban Reduces Recurrent VTE
WEDNESDAY, Nov. 30, 2022 (HealthDay News) -- For patients with isolated distal...
Health Highlights: May 13, 2022
Big rise in esophageal cancers among middle-aged Americans. Between 2012 and...